pharmacologynews.net pharmacologynews.net

pharmacologynews.net

Pharmacology Xagena News

Two new medicines for advanced kidney cancer: Cabometyx and Kisplyx. The European Medicines Agency ( EMA ) has recommended granting marketing authorisations in the European Union ( EU ) for two medicines for the treatment of advanced renal cell carcinoma, Cabometyx . Differentiated thyroid cancer: Lenvatinib, an orally administered multiple receptor tyrosine kinase inhibitor. Treatment of venous thromboembolism. The Food and Drug Administration ( FDA ) has approved Mekinist ( Trametinib ) for use in comb...

http://www.pharmacologynews.net/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR PHARMACOLOGYNEWS.NET

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.6 out of 5 with 12 reviews
5 star
9
4 star
1
3 star
2
2 star
0
1 star
0

Hey there! Start your review of pharmacologynews.net

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.6 seconds

FAVICON PREVIEW

  • pharmacologynews.net

    16x16

  • pharmacologynews.net

    32x32

  • pharmacologynews.net

    64x64

  • pharmacologynews.net

    128x128

  • pharmacologynews.net

    160x160

  • pharmacologynews.net

    192x192

CONTACTS AT PHARMACOLOGYNEWS.NET

XAGENA DI CARLO FRANZINI

via Q●●●●●nno 9

Mi●●no , 20122

IT

View this contact

Carlo Franzini

Carlo Franzini

via Q●●●●●nno 9

Mi●●no , 20122

IT

39 02●●●●●30029
39 02●●●●●33168
ma●●●●●●●@xagena.it

View this contact

Register.it S.p.A.

Register.it S.p.A.

Via Mo●●●●●●ri s/n

Be●●mo , 24126

IT

39 03●●●●●30400
39 03●●●●●30312
su●●●●●@register.it

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2005 February 23
UPDATED
2014 March 20
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 19

    YEARS

  • 2

    MONTHS

  • 29

    DAYS

NAME SERVERS

1
ns1.register.it
2
ns2.register.it

REGISTRAR

REGISTER.IT SPA

REGISTER.IT SPA

WHOIS : whois.register.it

REFERRED : http://we.register.it

CONTENT

SCORE

6.2

PAGE TITLE
Pharmacology Xagena News | pharmacologynews.net Reviews
<META>
DESCRIPTION
Two new medicines for advanced kidney cancer: Cabometyx and Kisplyx. The European Medicines Agency ( EMA ) has recommended granting marketing authorisations in the European Union ( EU ) for two medicines for the treatment of advanced renal cell carcinoma, Cabometyx . Differentiated thyroid cancer: Lenvatinib, an orally administered multiple receptor tyrosine kinase inhibitor. Treatment of venous thromboembolism. The Food and Drug Administration ( FDA ) has approved Mekinist ( Trametinib ) for use in comb...
<META>
KEYWORDS
1 toggle navigation
2 mappa
3 xagena
4 chi siamo
5 news it
6 news en
7 medicinanews
8 medicinenews
9 partner
10 cardiologia
CONTENT
Page content here
KEYWORDS ON
PAGE
toggle navigation,mappa,xagena,chi siamo,news it,news en,medicinanews,medicinenews,partner,cardiologia,news,farmaci,focus,oncologia,immunoterapia,oncohub,oncodermatologia,oncoematologia,oncogastroenterologia,oncogeriatria,oncoginecologia,onconeurologia
SERVER
nginx
POWERED BY
PleskLin
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Pharmacology Xagena News | pharmacologynews.net Reviews

https://pharmacologynews.net

Two new medicines for advanced kidney cancer: Cabometyx and Kisplyx. The European Medicines Agency ( EMA ) has recommended granting marketing authorisations in the European Union ( EU ) for two medicines for the treatment of advanced renal cell carcinoma, Cabometyx . Differentiated thyroid cancer: Lenvatinib, an orally administered multiple receptor tyrosine kinase inhibitor. Treatment of venous thromboembolism. The Food and Drug Administration ( FDA ) has approved Mekinist ( Trametinib ) for use in comb...

INTERNAL PAGES

pharmacologynews.net pharmacologynews.net
1

Relapsing multiple sclerosis: a novel PEGylated Interferon beta-1a | Pharmacology Xagena

https://www.pharmacologynews.net/articolo/relapsing-multiple-sclerosis-a-novel-pegylated-interferon-beta-1a

Banca dati di FarmacoVigilanza. Banca dati per una ricerca mirata in Medicina. Indice analitico in Medicina. Banca dati sui Farmaci. Banca dati di Medicina. Banca dati di news Headlines. Relapsing multiple sclerosis: a novel PEGylated Interferon beta-1a. A study has evaluated a novel PEGylated form of Interferon beta-1a ( PEG-IFN beta-1a; Plegridy ), a potential first-line treatment for relapsing multiple sclerosis, in healthy volunteers. PEG-Interferon beta-1a was well tolerated, with only transient red...

2

Multiple drug-resistant tuberculosis: Bedaquiline shows efficacy, but concern for hepatotoxicity | Pharmacology Xagena

https://www.pharmacologynews.net/articolo/multiple-drug-resistant-tuberculosis-bedaquiline-shows-efficacy-but-concern-for-hepatotoxicity

Banca dati di FarmacoVigilanza. Banca dati per una ricerca mirata in Medicina. Indice analitico in Medicina. Banca dati sui Farmaci. Banca dati di Medicina. Banca dati di news Headlines. Multiple drug-resistant tuberculosis: Bedaquiline shows efficacy, but concern for hepatotoxicity. MDR-TB and XDR-TB are more difficult to manage, cure rate with second line drugs is very less and relapse rate is very high. Bedaquiline is the first compound from the new class diarylquinolines that acts by inhibiting bacte...

3

Hepatitis C: new regimens with direct acting antivirals | Pharmacology Xagena

https://www.pharmacologynews.net/articolo/hepatitis-c-new-regimens-with-direct-acting-antivirals

Banca dati di FarmacoVigilanza. Banca dati per una ricerca mirata in Medicina. Indice analitico in Medicina. Banca dati sui Farmaci. Banca dati di Medicina. Banca dati di news Headlines. Hepatitis C: new regimens with direct acting antivirals. The approval of two hepatitis C virus ( HCV ) protease inhibitors by the FDA ( Food and Drug Administration ) in 2011, Boceprevir ( Victrelis ) and Telaprevir ( Incivo, Incivek ), marked the start of a new chapter in hepatitis C treatment. The following are summari...

4

Pharmacology Xagena News

https://www.pharmacologynews.net/news

Banca dati di FarmacoVigilanza. Banca dati per una ricerca mirata in Medicina. Indice analitico in Medicina. Banca dati sui Farmaci. Banca dati di Medicina. Banca dati di news Headlines. Two new medicines for advanced kidney cancer: Cabometyx and Kisplyx. The European Medicines Agency ( EMA ) has recommended granting marketing authorisations in the European Union ( EU ) for two medicines for the treatment of advanced renal cell carcinoma, Cabometyx . Treatment of venous thromboembolism. First approved co...

5

Treatment of venous thromboembolism | Pharmacology Xagena

https://www.pharmacologynews.net/articolo/treatment-of-venous-thromboembolism

Banca dati di FarmacoVigilanza. Banca dati per una ricerca mirata in Medicina. Indice analitico in Medicina. Banca dati sui Farmaci. Banca dati di Medicina. Banca dati di news Headlines. Treatment of venous thromboembolism. Venous thromboembolism ( VTE ), comprising deep vein thrombosis ( DVT ) and pulmonary embolism ( PE ), is a common, potentially lethal condition with acute morbidity. Patients with pulmonary embolism can also be treated in the acute phase as outpatients, a decision dependent on progno...

UPGRADE TO PREMIUM TO VIEW 10 MORE

TOTAL PAGES IN THIS WEBSITE

15

OTHER SITES

pharmacologylist.com pharmacologylist.com

pharmacologylist.com -&nbspThis website is for sale! -&nbsppharmacology list Resources and Information.

The owner of pharmacologylist.com. Is offering it for sale for an asking price of 700 EUR! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

pharmacologymath.com pharmacologymath.com

PharmacologyMath.com

PharmacologyMath.com is For Sale for $524.30!

pharmacologymatters.org pharmacologymatters.org

Welcome pharmacologymatters.org - BlueHost.com

Web Hosting - courtesy of www.bluehost.com.

pharmacologymcqs.com pharmacologymcqs.com

Pharmacology MCQs

Multiple choice questions in Pharmacology for medical and pharmacy students and doctors who prepare for FCPS, USMLE, MRCP, PLAB and other boards. Saturday, March 10, 2018. A 48 year old man is admitted to the hospital for a scheduled surgery. Two days later, he develops fever, chills, cough and chest pain. This hospital has reported several cases of methicillin-resistant Staphylococcus aureus (MRSA) in the last 3 months. What should have been given to this patient to prevent his infection with MRSA?

pharmacologymnemonics.blogspot.com pharmacologymnemonics.blogspot.com

Pharmacology Mnemonics - Flash Cards

Pharmacology Mnemonics - Flash Cards. Pharmacology Mnemonics and Pharmacology Flash Cards for your Pharma Studies. Part of several metalloenzymes. Deficiencies only in severely protein-deprived pts and pts. w/prolonged parenteral feeding. Present in vitamin B­. No known deficiency states. Present in several enzymes, required for normal bone structure. Excess limited to manganese miners. Present in bones and teeth. Fluoridation of drinking water at 1 ppm. Dental caries by 30-40%. Excess ( 10 ppm in water).

pharmacologynews.net pharmacologynews.net

Pharmacology Xagena News

Two new medicines for advanced kidney cancer: Cabometyx and Kisplyx. The European Medicines Agency ( EMA ) has recommended granting marketing authorisations in the European Union ( EU ) for two medicines for the treatment of advanced renal cell carcinoma, Cabometyx . Differentiated thyroid cancer: Lenvatinib, an orally administered multiple receptor tyrosine kinase inhibitor. Treatment of venous thromboembolism. The Food and Drug Administration ( FDA ) has approved Mekinist ( Trametinib ) for use in comb...

pharmacologynow.org pharmacologynow.org

PharmacologyNow

Wwwpharmacologynow.org is a work in progress! If you listen hard enough you’ll be able to hear the tappity, tap, tap of keys as we’re busily preparing content. But while you’re waiting, why not take a sneak peek at some of the exciting things we’ve been getting up to? Learn about the science of chocolate with Professor Clive Page, Dr Mark Miodownik, Dr Andrea Sella and master chocolatier Keith Hurdman. Or check our the science behind a curry. Leave a Reply Cancel reply. Enter your comment here.

pharmacologyonline.com pharmacologyonline.com

This Web site coming soon

If you are the owner of this web site you have not published (or incorrectly published) your web site. For information on publishing your web site, see. Publishing Your Web Site.

pharmacologyonline.silae.it pharmacologyonline.silae.it

PharmacologyOnLine | Front

Dedicated to the Memory of Ludovico Sorrentino, Emeritus Pharmacology Professor (1932-2010). Sat, 14 Apr 2018 20:22:02 0200. Bull;Abstracts Book of Nutriketo 1st edition. Bull;Abstracts Book of 25º SILAE Congress. Bull;Abstracts Book of 1º ISHS. Bull;Abstracts Book of 23º SILAE Congress of Marsala. PhOL - Pharmacology OnLine. Accepts submissions, presented as original research (Archives and Young Researchers section), short papers, reviews, correspondence (Newsletter section) and case reports (Case Repor...

pharmacologyonline.unisa.it pharmacologyonline.unisa.it

Home

Didattica a.a. 2015/16. Rassegna stampa e Comunicazione. Relazioni con il pubblico. Servizi on line studenti. Servizi on line docenti. Stazione Meteo di Ateneo. Bandi concorsi e avvisi. Qualità e valutazione in Ateneo. Presidio Qualità di Ateneo. Pharmacologyonline is changing its web paltform and all pages are migrating. So only new articles are avaliable (for 2011 sections). Other sections (before 2011) will be published during next months. Accepts submissions, presented as original research (Archives ...